4559:TYO
Zeria Pharmaceutical Co Ltd
¥2,068.00
arrow_downward
-1.29%(-27.00) 1D
Nov 20, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
¥2,068
High
¥2,088
Low
¥2,058
Mkt. cap
103.65B
Avg. vol.
132.53K
Volume
91.70K
Dividend
2.42%
Quarterly dividend
¥13
Ex-dividend date
Mar 30, 2027
P/E ratio
8.54
52-wk high
¥2,434
52-wk low
¥1,895
EPS
¥242
Shares outstanding
50.11M
No. of employees
2K
Open
¥2,068
High
¥2,088
Low
¥2,058
Mkt. cap
103.65B
Avg. vol.
132.53K
Volume
91.70K
Dividend
2.42%
Quarterly dividend
¥13
Ex-dividend date
Mar 30, 2027
P/E ratio
8.54
52-wk high
¥2,434
52-wk low
¥1,895
EPS
¥242
Shares outstanding
50.11M
No. of employees
2K
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
The S&P 500 Heads Into Thanksgiving Below Its Peak. Here's How the Holiday Week Has Usually Gone Since 1950.
24/7 Wall St.
·
25 minutes ago
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
Beinsure
·
2 hours ago
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
cwibc.co.id
·
1 hour ago
S&P 500 Tech Sector Falls 23% Into Bear Market
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1.75K
FoundedDec 22, 1955
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitezeria.co.jp